Notably, PKP2 replenishment therapy markedly improved cardiac function and attenuated fibrotic remodeling in post‐myocardial infarction HF mouse models, thereby providing critical evidence for the therapeutic potential of PKP2 in cardiac disorders. This evidence concerns the gene PKP2 and myocardial infarction.